IRL757, potential 1st apathy treatment, begins Phase 1 testing
Dosing has begun in a Phase 1 clinical trial evaluating the safety and efficacy of IRL757, an oral…
Read MoreExperience In Health
Dosing has begun in a Phase 1 clinical trial evaluating the safety and efficacy of IRL757, an oral…
Read More